Intercept Pharmaceuticals: Q2 Earnings Insights

Intercept Pharmaceuticals ICPT reported its Q2 earnings results on Wednesday, August 3, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Intercept Pharmaceuticals missed estimated earnings by 525.0%, reporting an EPS of $-0.25 versus an estimate of $-0.04.

Revenue was down $24.82 million from the same period last year.

Last quarter the company beat on EPS by $0.32 which was followed by a 1.63% drop in the share price the next day.

Here's a look at Intercept Pharmaceuticals's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	-0.90	-1.10	-1.09	-1.21
EPS Actual	-0.58	-1.23	-0.63	-0.33
Revenue Estimate	90.49M	92.38M	83.02M	82.95M
Revenue Actual	88.58M	92.40M	92.83M	96.58M

To track all earnings releases for Intercept Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.